← LeaderboardsInvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Neurocrine Biosciences, Inc.
San Diego, CA
$6,318,605
Total funding
18
Grants
Funding mix
By agency
NIH$6,318,605 · 18
By mechanism
R44$4,239,836 · 4
R43$1,905,937 · 13
R41$172,832 · 1
Investigators at Neurocrine Biosciences, Inc.
InvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Exposure= the full size of every grant they're on ($1M each).
Rising Stars
First grant in the last 5 yrs
Not enough data
Emerging Leaders
6–10 yrs in
Not enough data
Largest grants
A Screening Library for Peptide-Activated GPCR's$889,087
R44 · FY2002 · GM
CRF RECEPTOR ANTAGONISTS IN NEUROPROTECTION$666,805
R44 · FY2001 · NS
A Screening Library for Peptide-Activated GPCR's$638,359
R44 · FY2003 · GM
CRF RECEPTOR ANTAGONISTS IN NEUROPROTECTION$635,649
R44 · FY2000 · NS
Novel Non-Peptide Antagonists of the GnRH Receptor$471,580
R44 · FY2001 · HD
Novel Non-Peptide Antagonists of the GnRH Receptor$471,580
R44 · FY2002 · HD
Novel non-peptide antagonist of the MCH receptor$466,776
R44 · FY2003 · DK
A SCREENING LIBRARY FOR PEPTIDE-ACTIVATED GPCR'S$240,527
R43 · FY2000 · GM
Melanocortin-4 Receptor Antagonists$207,018
R43 · FY2001 · CA
Corticotropin Releasing Factor Receptor Function in CNS$170,479
R43 · FY2002 · MH
Selective CRF Antagonists for Bowel Disorders$139,497
R43 · FY2002 · DK
Novel non-peptide agonists of the melanocortin receptor$139,336
R43 · FY2002 · DK
NOVEL NON-PEPTIDE ANTAGONIST OF THE MCH RECEPTOR$138,733
R43 · FY2001 · DK
Nonpeptide Antagonists of CCR-7 for Immunosuppression$137,959
R43 · FY2002 · NS
Brain-penetrating H-3 Receptor Agonists for Insomnia$136,412
R43 · FY2005 · NS
CRF-Type-2 Receptor Antagonists for Anxiety$133,540
R43 · FY2002 · MH
DEVELOPMENT OF A TOXIC FUSION PROTEIN FOR BRAIN TUMORS$133,067
R43 · FY2000 · CA
Novel CRF antagonists for inflammation and pain$130,048
R43 · FY2002 · AR
Hypocretins and Their Role in the Control of Sleep$117,853
R41 · FY2001 · NS
NOVEL NON-PEPTIDE ANTAGONIST OF THE GNRH RECEPTOR$99,931
R43 · FY2000 · HD